Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.80
Ask: 3.84
Change: 0.09 (2.43%)
Spread: 0.04 (1.053%)
Open: 3.80
High: 3.80
Low: 3.80
Prev. Close: 3.71
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Argentina approves Harpin as a seed treatment

1 Sep 2021 07:00

RNS Number : 1012K
Plant Health Care PLC
01 September 2021
 

RNS

1 September 2021

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

Argentina approves Harpin ab for use as a seed treatment in Corn and Soybeans

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce the registration approval of Harpin ab for use as a seed treatment in Argentina.

 

The regulatory process in Argentina for agricultural products involves detailed review and approval by Senasa, the Country's National Food Safety and Quality Service, which classified Harpin ab as a biostimulant organic-chemical fertilizer. This confirms the Argentinian government's commitment to promoting cost effective, sustainable and safe products.

 

Highlights

· Corn and soybeans are the first crops to receive regulatory approval for Harpin ab in Argentina.

· Argentina has 24 million hectares (60 million acres) of corn and soybeans planted in the current season. Growers spent more than $100m on soybean seed treatments in Argentina in the most recent season. The size of the biological market in soybeans is growing rapidly and was about $75m in 2021.

· The Company is currently working with multiple organizations that are evaluating Harpin ab and will select in-country distribution partners in due course.

 

Harpin ab works by triggering the plant's own self defense systems, leading to a robust physiological response, in a manner similar to vaccinations in humans. The plant responds with improved crop quality, nutrient use efficiency, tolerance to abiotic stress and ultimately, increased yield. Being a biological product, Harpin αβ has a very favorable human and environmental safety profile.

 

Chris Richards, CEO of Plant Health Care, said: ‟Harpin ab registration in Argentina is key to the further expansion of Harpin ab use into large row crop markets."

 

 

For further information, please contact:

 

Plant Health Care plc- Tel: +1 919 926 1600

Chris Richards, CEO

 

Arden Partners plc - Nomad & Joint Broker Tel: +44 (0) 20 7614 5900

John Llewellyn-Lloyd / Antonio Bossi

 

Cenkos Securities plc - Joint Broker Tel: +44 (0) 20 7391 8900

Neil McDonald / Peter Lynch

 

Vox Markets - Digital investor relations Tel: +44 (0) 7866 384707

Paul Cornelius / Kat Perez

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile. Find out more at Vox Markets and the company website: www.planthealthcare.com

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSDLFDSEFSELA
Date   Source Headline
9th May 20131:20 pmRNSResult of AGM
7th May 201310:00 amRNSDirector/PDMR Shareholding
3rd May 20137:00 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSTotal Voting Rights
25th Apr 20137:00 amRNSPHC and Arysta LifeScience sign license agreement
19th Apr 20133:30 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:33 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:31 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:31 pmRNSTR-1 Notification of Major Interest in Shares
16th Apr 20138:23 amRNSRe. Investment
15th Apr 20131:30 pmRNSResult of General Meeting
8th Apr 20135:45 pmRNSPublication of Annual Report and Notice of AGM
2nd Apr 20137:00 amRNSConfirmation of Board Changes
27th Mar 20137:00 amRNSPosting of Circular to Shareholders
26th Mar 20134:19 pmRNSBoard Changes
26th Mar 20134:19 pmRNSPlacing and Subscription
26th Mar 20134:18 pmRNSFinal Results
20th Mar 201311:35 amRNSPHC reaches milestone agreement with Germains
11th Mar 20137:00 amRNSMarket Update
19th Feb 20135:45 pmRNSBlock Listing Six-Monthly Return
24th Jan 20139:30 amRNSHarpin field trials results
18th Jan 20135:00 pmRNSNotification of Major Interest in Shares
10th Jan 201312:45 pmRNSTrading Update
31st Dec 201212:25 pmRNSTotal Voting Rights
30th Nov 201211:45 amRNSTotal Voting Rights
2nd Nov 201212:15 pmRNSNotification of Major Interest in Shares
23rd Oct 20127:00 amRNSNotification of Major Interest in Shares
22nd Oct 20122:00 pmRNSNotification of Major Interest in Shares
19th Oct 20123:10 pmRNSNotification of Major Interest in Shares
9th Oct 20127:00 amRNSStrong uptake of new product
8th Oct 20127:00 amRNSNotification of Major Interest In Shares
13th Sep 20127:00 amRNSSignificant progress in SA 2013 maize crop season
31st Aug 20125:00 pmRNSTotal Voting Rights
30th Aug 20122:47 pmRNSHolding(s) in Company
28th Aug 20129:40 amRNSPosting of Interim Report
24th Aug 20122:30 pmRNSDirector/PDMR Shareholding
20th Aug 201212:45 pmRNSAIM Blocklisting Interim Return
20th Aug 20127:00 amRNSHalf Yearly Report
14th Aug 20127:00 amRNSHolding(s) in Company
1st Aug 201212:15 pmRNSDirectorate Change
30th Jul 201212:15 pmRNSNotification of Major Interest in Shares
27th Jul 20127:00 amRNSPotato yield increased through PHC's Harpin
18th Jul 20127:00 amRNSHolding(s) in Company
17th Jul 20127:00 amRNSHolding(s) in Company
28th Jun 20127:00 amRNSHolding(s) in Company
17th May 20127:00 amRNSResearch cooperation with University of Arkansas
3rd May 201212:00 pmRNSHolding(s) in Company
1st May 20125:00 pmRNSTotal Voting Rights
27th Apr 201211:49 amRNSResearch Agreement with Arysta LifeScience

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.